DOCSLIB.ORG

And Multiple Sclerosis Particular Problem, I Wish to Make the Follow

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
And Multiple Sclerosis Particular Problem, I Wish to Make the Follow 524 Maters arising prolong the lives of those suffering, thereby Most of these problems are not taken into 6 Poser C, Paty D, Scheinberg L, et al. New J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.6.524-b on 1 June 1992. Downloaded from providing the necessity for self-action by the consideration in Sibley's article. diagnostic criteria for multiple sclerosis. Ann patient. It is germane to point out that the "scien- Neurol 1983;13:227-31. Perhaps when we advise patients and tific" evidence of epidemiology and biostatis- families who face difficult decisions, we tics overlooks the fact that such studies can at Sibley et al reply: would be better to heed the available evi- best only be estimates within a cohort and dence about who will do well and who will do cannot be generalised; epidemiological stud- We age- and sex-matched MS patients with badly rather than withholding recommenda- ies are most useful in providing aetiological healthy controls solely to establish the degree tions because unduly cautious statisticians clues but cannot be used to deny possible of accident-proneness of MS patients. It choose to neglect the downside effects of causal relationships.2 As was pointed out by probably needs to be clearly restated that the their theoretical arguments. Neurologists are Schoenberg, "Statistical significance (or lack patients were used as their own controls in an especially favourable position to under- thereof) does not equal biological when they were not "at risk". stand the misery that accompanies chronic, significance". Physical trauma had no positive influence overwhelming brain damage. This knowledge It is difficult to understand, on the basis of on either exacerbation rate or progression of places them in a position to understand the what is already known about the pathogen- MS in our group of MS patients as a whole, humane needs in such cases and advise esis of MS, how trauma such as laceration of or in various subgroups divided according to families accordingly. the hand, contusion of the right finger, a root sex, age, degree of disability, or duration of FRED PLUM canal procedure, or a thorn in the foot can disease-all of these data could not Department ofNeurology, be and Neuroscience, possibly lead to the appearance or recurrence presented in our paper in the interests of The New York Hospital-Cornell Medical Center, of symptoms of MS. Sibley et al dismiss the brevity. We have not analysed separately 525 East 68th Street, alteration of the blood-brain barrier in the based on sites of residence or socioeconomic New York, NY 10021, USA genesis of the MS lesion; in doing so they factors. disregard the numerous recent publications I am sure that Dr Poser is aware that we 1 Bates D. Defining prognosis in medical coma. which have amply confirmed this fact, have no way ofidentifying MS patients whose J Neurol, Neurosurg Psychiatry 1991;54: including statements by such authorities as disease has not 569-7 1. yet been recognised. His 2 Levy DE, Bates D, Caronna JJ, et al. Prognosis McDonald and Barnes' who commented statement that some of them will not have in non-traumatic coma. Ann Int Med that "A consistent, very early event is a symptoms until subjected to trauma, makes 198 1;94:293-301. breakdown of the blood-brain barrier which causative assumptions that our study data do is largely repaired over weeks, leading to not support. Bates replies: marked changes in the size of acute lesions" With regard to his comments concerning I am grateful to Professor Plum for emphasis- and by Compston' who wrote, "Blood-brain the validity of statistical methods, we believe ing the important exclusions in the Inter- barrier damage is necessary early in the that it is common scientific practice to national Study on Prognosis in Non-trau- development of focal demyelination". generalise on the basis of data obtained in matic Coma and appreciate his comments One cannot expect that all, or even most representative samples of a group. The cal- relating to the use of unfavourable early signs. MS patients will have exacerbations follow- culation of annual exacerbation rates was for I did not intend to suggest that clinical or ing trauma, since it is a common experience the convenience of the reader; the chi-square laboratory indicators of poor outcome were for MS patients to have repeated viral infec- calculations were done on actual exacerba- not to be used as part of the process to make tions without changes in the course of their tion numbers during periods at risk and not decisions in patient management, and am disease. at risk for trauma, not on the annual rates. very conscious of what Professor Plum refers The relationship between trauma to the Our study tested the hypothesis, advanced to as the "downside statistical feature" of head, neck or back that I have supported, is by others, that trauma, including peripheral prolonging an insentient life and the con- based upon clinical, neuropathological, and trauma, could cause exacerbations ofMS. We sequent burden on the family. My purpose experimental evidence which were reviewed are happy to see that Dr Poser agrees that was rather to emphasise that predictors of in 1986' and based on the obligatory step of peripheral trauma, at least, can be dismissed poor outcome should not be used as the sole the alteration of the blood-brain barrier for as a cause. He continues to believe, however, factor in making decisions about life support, the formation of the MS lesion. This has now that CNS trauma that causes a breach in the though they should be used in discussions been amply documented. blood-brain barrier can cause new lesions in with relatives of the patient and with our Additional problems seemed to have MS. The anecdotal case reports that form the colleagues in helping to arrive at an appro- plagued this study: for reasons which are not clinical basis for his belief are selected from priate clinical decision. explained, symptoms alone are not recog- large numbers of cases where there is no http://jnnp.bmj.com/ nised as exacerbations. Nevertheless, diplo- temporal relationship between trauma and pa, paresthesiae and vertigo, classic symp- exacerbation and cannot be accepted as valid toms of MS are quite often unaccompanied evidence that trauma is a risk factor in MS. by objective changes in the neurological We agree that if trauma were a causative A prospective study of physical trauma examination. It is curious that Sibley et al factor that all traumas would not be followed and multiple sclerosis used 48 hours' duration for an exacerbation by excacerbations, since many new lesions of as opposed to the more generally accepted 24 MS are symptomatic. However, a study such I read with great interest the article by Sibley hours.6 Finally, it is difficult to draw any as ours should have shown a higher propor- et al.' Because of my own involvement in this conclusions from data given on the basis of tion of excacerbations when at risk for on September 24, 2021 by guest. Protected copyright. particular problem, I wish to make the mean annual exacerbation rates for the sim- trauma in 170 patients over a five year period following comments. ple reason that exacerbations in MS are never since the frequency of trauma was high. There can be no more difficult task than to uniformly distributed; periods of complete The Multiple Sclerosis NMR Group at conduct epidemiological surveys of multiple quiescence lasting several years not uncom- Queen Square has found that in some sclerosis (MS) because of its unpredictability monly occur after a series ofseveral exacerba- patients gadolinium leakage may precede and symptomatic variability. It is therefore tions within a single year. other evidence of new lesion formation; they unsuitable for measurements with the yard- CHARLES M POSER attribute this to inflammation, not to trau- sticks currently at hand. Indeed, to design an Department ofNeurology, ma.' Certainly barrier breakdown due to the Harvard Medical School, epidemiologically valid study, it would be Boston, MA, USA perivenular inflammatory lesions is an early necessary to match MS patients (not just event, but we believe that the cause of this healthy controls) for age, sex, ethnic origin, 1 Sibley WA, Bamford CR, Clark K, Smith MS, inflammatory response is unknown and our duration and geographic sites of residence, Laguna JF. A Prospective study of physical data suggest that trauma is not a factor in living and socio-economic environment, trauma and multiple sclerosis. Y Neurol Neu- new lesion formation. duration and of type of rosurg Psychiatry 1991;54:584-9. severity disease, 2 Schoenberg B. Neurological epidemiology. New Our decision to define exacerbations on clinical course, stage of activity, and number York: Raven Press, 1978;1 1, 43. the basis of objective neurological changes and location oflesions using modern imaging 3 McDonald I, Barnes D. Lessons from magnetic only are in keeping with the Schumacher techniques such as MRI. It would be neces- resonance imaging in multiple sclerosis. Committee criteria for Trends Neurosci 1989;12:376-9. definition of a sary to consider not only patients who have 4 Compston A. Immunological aspects of multi- relapse.2 The 48 hour minimum duration of already been diagnosed as having MS, but ple sclerosis. In: MatthewsW (ed) McAlpine's new symptoms was an arbitrary departure also those who have been symptomatic but Multiple Sclerosis, 2nd ed. Edinburgh: Chur- from the Schumacher criteria to help ensure not yet recognised as well as all those chill-livingstone, 1991; 330. patients 5 Poser C. The pathogenesis of multiple sclerosis: that fluctuations in symptoms due to fatigue whose symptoms of underlying MS will not a critical reappraisal.
Load more

Recommended publications
  • Updated Criteria for Diagnosing Multiple Sclerosis
    r e v i e w a r t i c l e Updated criteria for diagnosing Multiple Sclerosis or in the case of progressive MS, a slow or step- Key take home messages wise progression of disability over a period of • The diagnostic criteria for MS have at least six months been recently updated • and objective clinical evidence of lesions in • These criteria should only be applied two or more distinct sites in the white matter to populations in whom MS is of the central nervous system common and patients who present • with no more satisfactory explanation. Peter Brex with typical symptoms for which no The Schumacher criteria were purely clinical, MB BS, MD, FRCP is a Consultant Neurologist at King’s College Hospital better explanation can be found although investigations were encouraged (blood, NHS Foundation Trust. He trained in • All patients with suspected MS should urine, chest X-ray, CSF analysis) to exclude London and was appointed to his current have an MRI brain scan; spinal cord alternative conditions. role in 2005. He specialises in multiple imaging is not mandatory Over the next few years modifications to the sclerosis, with a particular interest in early 2,3 prognostic markers and the management • Unmatched oligoclonal bands in the Schumacher criteria were published but in 1983 of MS during pregnancy. CSF can be used as a substitute for the Schumacher criteria were replaced by criteria demonstrating dissemination in time, developed by a committee chaired by Charles allowing an earlier diagnosis than was Poser (1923 – 2010).4 The Poser criteria incorpor- previously possible ated laboratory and clinical tests developed in the previous decade to support the diagnosis with ‘paraclinical evidence’ of lesions.
    [Show full text]
  • (Pre-Allison & Millar) Ipsen Criteria: 1939-48, Boston, MA
    Early criteria (pre-Allison & Millar) Ipsen criteria: 1939-48, Boston, MA USA1 - Probable MS o Those cases with records presenting convincing evidence - Possible MS o Those cases whose evidence was more doubtful. Ipsen acknowledges these allocations are fairly arbitrary but also notes that absolutely certainty of diagnosis is impossible except by autopsy, a limitation we are similarly affected by even today. Westlund & Kurland: 1951, Winnipeg, MT Canada & New Orleans, LA USA2 Diagnostic groupings as follows, with no explicit requirements for each, rather deferring to the discretion of the examining neurologist: - Certain MS - Probable MS - Possible MS o In this class, the changes for and against MS were considered approximately even - Doubtful, unlikely or definitely-not MS2 Sutherland criteria: 1954, Northern Scotland3 - Probable MS o This category for patients in whom the history, the results of clinical examination and, where available, hospital investigations, indicated that the diagnosis of MS was beyond reasonable doubt. - Possible MS o Patients in whom a diagnosis of MS appears justifiable but in which the diagnosis could not be established beyond reasonable doubt; o This group also included patients who did not wish to be examined or could not be seen – review of hospital records for these patients suggested a diagnosis of MS - Rejected cases o Patients found to be suffering from a disease other than MS Allison & Millar Criteria and variants Allison & Millar criteria: 1954, Northern Ireland4 - Early disseminated sclerosis: 1) this category for patients with little in the way of symptomatic presentation but with a recent history consistent with disease onset, i.e. optic neuritis, ophthalmoplegia (double vision), vertigo, sensory problems like pins & needles or numbness, or motor problems like weakness.
    [Show full text]
  • Nayakphd2018.Pdf
    This work is protected by copyright and other intellectual property rights and duplication or sale of all or part is not permitted, except that material may be duplicated by you for research, private study, criticism/review or educational purposes. Electronic or print copies are for your own personal, non- commercial use and shall not be passed to any other individual. No quotation may be published without proper acknowledgement. For any other use, or to quote extensively from the work, permission must be obtained from the copyright holder/s. 1 2 3 Structure and function of the visual pathway in demyelinating optic neuropathy Devaki Nayak Thesis submitted for degree of PhD June 2018 Keele University 4 Acknowledgments I take this opportunity to thank Professor Hawkins for all the help and advice that he provided me over the entire duration of work. I would like to thank the team at Keele Multiple Sclerosis Research Group for their help, friendship and humor throughout the period of research. I once again thank Professor Hawkins for guiding an Ophthalmologist to explore the world of MS in Neurology. I would like to thank Professor Peter Jones for his valuable input on statistical methodology and Professor Richard Strange for his weekly input on statistics from the very first recruitment into this project. I specially want to thank Dr. Ramachandran who spent considerable amount of time in guiding the project and helping with meetings with Professor Jones. I am also thankful to Janice Guildford who helped me with knowledge of existent database in the Keele Multiple Sclerosis Research Group.
    [Show full text]
  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis a Consensus Statement
    NEUROLOGICAL REVIEW Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis A Consensus Statement Mark S. Freedman, MSc, MD, FRCPC; Edward J. Thompson, DSc; Florian Deisenhammer, MD; Gavin Giovannoni, PhD; Guy Grimsley, PhD; Geoffrey Keir, PhD; Sten Öhman, PhD; Michael K. Racke, MD; Mohammad Sharief, PhD; Christian J. M. Sindic, MD, PhD; Finn Sellebjerg, MD, PhD, DMSci; Wallace W. Tourtellotte, MD, PhD ew criteria for the diagnosis of multiple sclerosis (MS) were published as the result of an internationally formed committee. To increase the specificity of diagnosis and to minimize the number of false diagnoses, the committee recommended the use of both clinical and paraclinical criteria, the latter involving information obtained from Nmagnetic resonance imaging, evoked potentials, and cerebrospinal fluid (CSF) analysis. Although rigorous magnetic resonance imaging requirements were provided, the “new criteria paper” fell short in terms of guidelines as to how the CSF analysis should be performed and simply equated the IgG index with isoelectric focusing, without any justification. The spectrum of parameters ana- lyzed and methods for CSF analysis differ worldwide and often yield variable results in terms of sensitivity, specificity, accuracy, and reliability, with no decided “optimal” CSF test for the diag- nosis of MS. To address this question specifically, an international panel of experts in MS and CSF diagnostic techniques was convened and the result was this article, representing a consensus of all the participants. These recommendations for establishing a standard for the evaluation of CSF in patients suspected of having MS should greatly complement the new criteria in ensuring that a correct diagnosis of MS is being made.
    [Show full text]
  • New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols
    SPECIAL ARTICLE New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols Charles M. Poser, MD,l Donald W. Paty, MD,’ Labe Scheinberg, MD,3 W. Ian McDonald, FRCP,4 Floyd A. Davis, MD,’ George C. Ebers, MD,‘ Kenneth P. Johnson, MD,’ William A. Sibley, MD,8 Donald H. Silberberg, MD,9 and Wallace W. Tourtellotte, MD” Several schemes for the diagnosis and clinical clas- Method and Procedure sification of multiple sclerosis (MS) have been ad- On April 26 and 27, 1982, the following persons participated vanced [l}. The best known is that published by in a Workshop on the Diagnosis of Multiple Sclerosis, held in Schumacher et alC31. The criteria for this scheme were Washington, DC, for the purpose of establishing new diag- established in order to select patients for participation nostic criteria for MS: Bruce Becker (National Naval Medical in therapeutic trials, and pertain only to what might be Center),Jerry Blaivas (Columbia), Keith Chiappa (Harvard), called definite MS. No provision was made for incor- Floyd Davis (Rush), Burton Drayer (Duke), George Ebers porating supportive laboratory data into the diagnostic (Western Ontario), Andrew Eism (British Columbia), criteria. Robert Herndon (Rochester, NY), Kenneth Johnson (Mary- As no reliable specific laboratory test for the diag- land), Ian McDonald (National Hospital, London), Dale nosis of MS has been discovered, the diagnosis remains McFarlin (NINCDS), Donald Paty, Co-chairman (British a clinical one, and there is still a need for clinical diag- Columbia),Janis Peyser
    [Show full text]
  • Swedish Neuroscience Institute
    Diagnosing MS MS can be difficult to diagnose. There is no test that is 100% certain in identifying who has the disease and who does not have the disease. This has led to the development of several sets of diagnostic criteria over the years. One of the first sets of criteria was known as the Schumacher criteria. These criteria required dissemination in both space and time, meaning that patients had to have more than one part of the nervous system involved (dissemination in space) at more than one time (dissemination in time). Dissemination is space and time is still a cornerstone of the diagnosis. The Schumacher criteria were followed by the Poser Criteria which included testing for spinal fluid and recognized degrees of certainty with the diagnosis. The best and most current set of criteria for diagnosing MS is the McDonald criteria. These were first developed in 2001 by an international panel in association with the National MS Society. The McDonald criteria were revised in 2005 and again in 2010. The 2010 revision to the McDonald criteria is the current standard for diagnosis. Overview The primary goal of the McDonald Criteria is to enable the diagnosis of MS sooner and to permit earlier treatment of MS. For clinical research trials it is important to ensure that those without a definite diagnosis of MS are not enrolled. The bottom line is that there have to be 2 attacks in time and at 2 locations. You can get the locations in time either by clinical attacks or by MRI changes over time.
    [Show full text]
  • MS Misdiagnosis— an Analysis from Case Studies
    6/6/2011 MS Misdiagnosis— An Analysis From Case Studies Joseph R. Berger, MD Ruth L. Works Professor and Chairman Department of Neurology University of Kentucky College of Medicine Chief of Department and Head of MS Center University of Kentucky Medical Center Lexington, Kentucky Disclosures Sources of Funding for Research: Bayer HealthCare Pharmaceuticals; Biogen Idec; EMD Serono, Inc. Consulting Agreements: Bayer HealthCare Pharmaceuticals; Biogen Idec; Genentech, Inc.; GlaxoSmithKline; Millennium Pharmaceuticals,,; Inc.; Perseid Other support: Bayer HealthCare Pharmaceuticals; Biogen Idec; Serono, Inc. Financial Interests/Stock Ownership: None Discussion of Off-Label, Investigational, or Experimental Drug Use: Cyclophosphamide, intravenous immunoglobulins A handful of patience is worth more than a barrel full of brains. Dutch Proverb 1 6/6/2011 Causes of Misdiagnosis • Diagnosis momentum • Diagnosis even on insufficient evidence becomes fixed in a doctor’s mind • Framing effects • Being swayed by subtle wording or focusing on certain aspects of a case more than others • Satisfaction of search • Stopping when you find a satisfying diagnosis • Confirmation bias (anchoring) • Dismissing material that does not fit with your diagnostic impression • Attribution error • Failing to consider a diagnosis that does not fit the prototype • Representativeness error • Failing to consider possibilities that contradict the prototype and base rate of disease • Failing to account for base rates (“If you hear hoof beats, think horses, not zebras”) •
    [Show full text]
  • Magnetization Transfer Imaging to Investigate Tissue Structure and Optimise Detection of Blood Brain Barrier Leakage in Multiple Sclerosis
    Magnetization Transfer Imaging to Investigate Tissue Structure and Optimise Detection of Blood Brain Barrier Leakage in Multiple Sclerosis Dr Nicholas Charles Silver, MBBS; MRCP A thesis submitted to the University of London for the degree of Doctor of Philosophy March 2001 NMR Research Unit Institute of Neurology University College London Queen Square London WCIN 3BG United Kingdom ProQuest Number: U643048 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643048 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract Magnetic resonance imaging (MRI) has become a powerful researeh tool for in vivo evaluation and monitoring of multiple sclerosis (MS). Conventional MRI techniques detect changes in the density or relaxation characteristies of “free” water protons. They are sensitive but lack pathological specificity. Magnetization transfer (MX) imaging provides a method for evaluating those protons “bound” to maeromolecular struetures. Part one of this thesis outlines the clinical and pathological features of MS and discusses the importance of demyelination and blood-brain barrier breakdown. An introduction to MRI and MX imaging techniques is provided.
    [Show full text]
  • Multiple Sclerosis Disease Modifying Therapies Update
    Practical Controversies in MS Lucas McCarthy, MD, MSc Neurologist, Director MS Center Practical Controversies How to approach common questions in the gray-zone of evidence- based practice? © 2016 Virginia Mason Medical Center The Evidence Free Zone © 2016 Virginia Mason Medical Center Practical Controversies in MS • Misdiagnosis of MS • Vitamin D testing / supplementation • Use of complimentary / experimental treatments • Treatment of Progressive MS © 2016 Virginia Mason Medical Center Poll Everywhere – Audience Participation Open cell phone or laptop to following link to participate in live questions https://pollev.com/MSsummit © 2016 Virginia Mason Medical Center Misdiagnosis of Multiple Sclerosis Misdiagnosis of MS Updated 2017 McDonald MS Diagnostic Criteria Easier to diagnosis = Easier to misdiagnose? © 2016 Virginia Mason Medical Center MS Diagnosis – 2017 Updated Criteria Lesions: ≥ 2 characteristic lesions (>3mm) in ≥ 2 different locations Symptoms: objective clinical evidence of at least 1 lesion Relapse: ≥ 1 characteristic clinical attack Changes over Time: ≥2 CSF Oligoclonal bands or >1 attack over time or new lesions over time (including enhancing and non-enhancing) *No other reasonable diagnosis © 2016 Virginia Mason Medical Center MS Diagnosis – Evolving Diagnostic Criteria MS Diagnostic Criteria Comments 1965 - Schumacher Criteria 2 attacks of neurologic symptoms > 24 hours in duration, separated by at least one month. No MRI yet 1983 - Poser Criteria Added cerebrospinal fluid (CSF) markers and Evoked Potentials to diagnostic
    [Show full text]
  • Prevalence of Multiple Sclerosis in Al Quseir City, Red Sea Governorate, Egypt
    Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Year: 2016 Volume: 12 Neuropsychiatric Disease and Treatment Dovepress Running head verso: El-Tallawy et al Running head recto: Epidemiology of multiple sclerosis in Egypt open access to scientific and medical research DOI: http://dx.doi.org/10.2147/NDT.S87348 Open Access Full Text Article ORIGINAL RESEARCH Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt Hamdy N El-Tallawy1 Background: Multiple sclerosis (MS) is a chronic and disabling disorder with considerable Wafaa M A Farghaly1 social effects and economic sequelae. It is one of the major causes of disability in young Reda Badry1 adults. Nabil A Metwally2 Objectives: This study aimed at detecting the prevalence of MS among the population of Ghaydaa A Shehata1 Al Quseir city. Tarek A Rageh1 Methods: This study is a part of door-to-door survey of major neurological disorders that was conducted in Al Quseir city, Red Sea Governorate, Egypt. The sample size was 33,285 persons. Mohamed Abd El Hamed1 The youngest patient was 17 years old. The number of people at and above 17 years of age Mahmoud R Kandil1 was 21,827. They were screened by three neurologists. Then, the positive cases were subjected 1Department of Neurology and to meticulous clinical evaluation by three staff members of Department of Neurology, Assiut Psychiatry, Assiut University Hospital, Assiut, Egypt; 2Department of University Hospital, Egypt. Essential investigations were done. For personal use only. Neurology and Psychiatry, Al Azhar Results: A total of three cases of MS were diagnosed with an age-specific prevalence $17 University Hospital, Assiut Branch, years of 13.7/100,000.
    [Show full text]
  • The Diagnosis of Multiple Sclerosis
    TheThe DiagnosisDiagnosis OfOf MultipleMultiple SclerosisSclerosis DRDR SAHERSAHER HASHEMHASHEM PROFPROF OFOF NEUROLOGYNEUROLOGY CAIROCAIRO UNIVERSITYUNIVERSITY ThereThere isis nono pathpath gnomonicgnomonic oror perfectperfect laboratorylaboratory testtest whichwhich maymay bebe usedused inin isolationisolation toto reliablyreliably diagnosediagnose MS.MS. TheThe keykey toto correctcorrect diagnosisdiagnosis isis typicalitytypicality TheThe duckduck testtest isis importantimportant ,, (( isis thisthis aa duck,duck, itit lookslooks likelike aa duck,duck, walkwalk likelike andand quacksquacks likelike aa duck,duck, thenthen itit isis probablyprobably aa duck.duck. duck, and QuestionQuestion OneOne WhatWhat isis thethe mostmost commoncommon mistakemistake duringduring MSMS diagnosis?diagnosis? TheThe mostmost commoncommon mistakemistake duringduring MSMS diagnosisdiagnosis isis aa falsefalse positivepositive attributionattribution thatthat isis makingmaking aa diagnosisdiagnosis ofof MSMS inin patientspatients whowho dondon ’’tt havehave MS.OftenMS.Often thisthis errorerror isis thethe resultresult ofof uncriticaluncritical oror causalcausal reliancereliance onon MRIMRI withoutwithout appropriateappropriate clinicalclinical correlationcorrelation 6262 patientspatients assessedassessed byby generalgeneral neurologistsneurologists andand reassessedreassessed byby otherother generalgeneral neurologistsneurologists usingusing McMc DonaldDonald ’’ss criteriacriteria andand foundfound 51%51% ofof MSMS patientspatients werewere notnot confirmed.confirmed.
    [Show full text]
  • THE DIAGNOSIS of MULTIPLE SCLEROSIS C B Tan
    C LEADING ARTICLE j THE DIAGNOSIS OF MULTIPLE SCLEROSIS C B Tan SINGAPORE MED J 1992; Vol 33: 561-562 Demyelinating diseases in adults, in which the pathology is tomatic dissemination in space or detect evidence of inflam- in the white matter predominantly of the central nervous sys- mation in the central nervous system are useful aids in the tem, are caused by a variety of viral infections and anoxic - diagnosis of MS. The risk of developing MS following an toxic conditions"). However, the most common primary isolated acute syndrome of brainstem or spinal cord is much demyelinating disease is multiple sclerosis (MS) which is char- higher in patients with disseminated lesions on MRI and in acterised by multifocal inflammatory demyelination in the cen- those with positive oligoclonal band1"). Similarly, the risk of nervous tral system and recognised by its relapsing and remit- developing MS in isolated optic neuritis may be higher in ting character. As there are no pathognomonic laboratory tests, patients who have abnormal white matter lesions on MRIOt). the diagnosis has always been a clinical one. Diagnostic crite- The existing diagnostic criteria for MS were revised at a Work- ria have continued to evolve since its delineation as a disease shop on the Diagnosis of Multiple Sclerosis in 1982 whereby entity by Charcot more than a century ago. The disease typi- paraclinical findings were incorporated for the purpose of ex- young cally occurs in women of northern European Caucasian tending the limits of the diagnostic criteria thus making a larger descent in temperate countries1). The prevalence of the disease reservoir of patients for investigative purposes101.
    [Show full text]